Mikko Puhakka - UEFConnect

Tiedot Julkaisut

Julkaisut

5 kappaletta

Re-treatment with varenicline is a cost-effective aid for smoking cessation
Kautiainen K, Ekroos H, Puhakka M, Liira H, Laine J, Linden K, Hahl J. 2016. Journal of medical economics. 2017; 20: 246-252
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: nordic bifurcation study 5-year follow-up results
Maeng M, Holm NR, Erglis A, Kumsars I, Niemelä M, Kervinen K, Jensen JS, Galløe A, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, et al. (including Puhakka M). 2013. Journal of the american college of cardiology. 62: 30-34
Smoking behaviour in European patients with established coronary heart disease
Scholte op Reimer W, de Swart E, de Bacquer D, Pyörälä K, Keil U, Heidrich J, Deckers JW, Kotseva K, Wood D, Boersma E, for the EUROASPIRE Investigators, Lehto S, Lehto R, Koukkunen H, Puhakka M, Savolainen K. 2006. European heart journal. 27: 35-41
Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation
Puhakka M, Magga J, Hietakorpi S, Penttilä I, Uusimaa P, Risteli J, Peuhkurinen K. 2003. Journal of cardiac failure. 9: 325-332
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II Euro Heart Survey Programme
EUROASPIRE II Study Group, Lehto S, Puhakka M, Pyörälä K, Kärkkäinen S, Lehto R. 2001. European heart journal. 22: 554-572